Therapeutic and research frontiers in fibromyalgia: integrating pathophysiology with innovative drug repurposing.

Joodi SA, Nawwar DA, Rasheed NOA, Ibrahim WW, Sayed HM.

Open source

DOI
10.1007/s10787-026-02349-5
Published
2026-07-23
Container
Inflammopharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10787-026-02349-5,
  title = {Therapeutic and research frontiers in fibromyalgia: integrating pathophysiology with innovative drug repurposing.},
  author = {Joodi SA and  Nawwar DA and  Rasheed NOA and  Ibrahim WW and  Sayed HM.},
  year = {2026},
  journal = {Inflammopharmacology},
  doi = {10.1007/s10787-026-02349-5},
  url = {https://doi.org/10.1007/s10787-026-02349-5}
}

RIS

TY  - JOUR
TI  - Therapeutic and research frontiers in fibromyalgia: integrating pathophysiology with innovative drug repurposing.
AU  - Joodi SA
AU  -  Nawwar DA
AU  -  Rasheed NOA
AU  -  Ibrahim WW
AU  -  Sayed HM.
PY  - 2026
JO  - Inflammopharmacology
DO  - 10.1007/s10787-026-02349-5
UR  - https://doi.org/10.1007/s10787-026-02349-5
ER  - 

APA

SA, J., DA, N., NOA, R., WW, I., & HM., S. (2026). Therapeutic and research frontiers in fibromyalgia: integrating pathophysiology with innovative drug repurposing.. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02349-5

Source records